Millipore Sigma Vibrant Logo

MAB8251 Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend

View Products on Sigmaaldrich.com
MAB8251
100 µL  
Recuperando precio...
No pudo obtenerse el precio
La cantidad mínima tiene que ser múltiplo de
Maximum Quantity is
Al finalizar el pedido Más información
Ahorró ()
 
Solicitar precio
Disponibilidad a confirmar
Disponibilidad a confirmar
Ingrese cantidad 
Suspendido
Cantidades limitadas disponibles
Debe confirmarse disponibilidad
    El resto: se avisará
      El resto: se avisará
      Se avisará
      Póngase en contacto con el Servicio de Atención al Cliente
      Contact Customer Service

      Ofertas especiales

       

      Póngase en contacto con el Servicio de Atención al Cliente

      Descripción

      Replacement Information

      Ofertas especiales

      Tabla espec. clave

      Species ReactivityKey ApplicationsHostFormatAntibody Type
      HIFMAscitesMonoclonal Antibody
      Description
      Catalogue NumberMAB8251
      Brand Family Chemicon®
      Trade Name
      • Chemicon
      DescriptionAnti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend
      References
      Product Information
      FormatAscites
      Control
      • Influenza Control Slides, Catalogue Number 5010-5
      PresentationAscites fluid containing no preservatives.
      Quality LevelMQ300
      Applications
      ApplicationThis Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend is validated for use in IF for the detection of Influenza A.
      Key Applications
      • Immunofluorescence
      Application NotesIndirect immunofluorescence at 1:100-1:1000.

      Optimal working dilutions must be determined by end user.
      Biological Information
      ImmunogenInfluenza A blend.
      CloneA1 & A3 Blend
      ConcentrationPlease refer to the Certificate of Analysis for the lot-specific concentration.
      HostMouse
      SpecificityAll subtypes of Influenza A (H1N1, H2N2 and H3N2 and H5N1). Specific for the nucleoprotein antigen. No cross-reactivity seen to Influenza B, Parainfluenza 1, 2 or Adenovirus or RSV.
      IsotypeIgG2a (A1) IgG1 (A3)
      Species Reactivity
      • Human
      Antibody TypeMonoclonal Antibody
      Purification MethodUnpurified
      Physicochemical Information
      Dimensions
      Materials Information
      Toxicological Information
      Safety Information according to GHS
      Safety Information
      Product Usage Statements
      Usage Statement
      • Unless otherwise stated in our catalog or other company documentation accompanying the product(s), our products are intended for research use only and are not to be used for any other purpose, which includes but is not limited to, unauthorized commercial uses, in vitro diagnostic uses, ex vivo or in vivo therapeutic uses or any type of consumption or application to humans or animals.
      Storage and Shipping Information
      Storage ConditionsMaintain for 1 year at -20°C from date of shipment. Aliquot to avoid repeated freezing and thawing. For maximum recovery of product, centrifuge the original vial after thawing and prior to removing the cap.
      Packaging Information
      Material Size100 µL
      Transport Information
      Supplemental Information
      Specifications
      Global Trade Item Number
      Número de referencia GTIN
      MAB8251 04053252265525

      Documentation

      Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend Ficha datos de seguridad (MSDS)

      Título

      Ficha técnica de seguridad del material (MSDS) 

      Anti-Influenza A Antibody, nucleoprotein, clones A1, A3 Blend Certificados de análisis

      CargoNúmero de lote
      MOUSE ANTI-INFLUENZA A 2470855
      MOUSE ANTI-INFLUENZA A MONOCLONAL ANTIBODY BLEND - 2145071 2145071
      MOUSE ANTI-INFLUENZA A MONOCLONAL ANTIBODY BLEND - 2441923 2441923
      MOUSE ANTI-INFLUENZA A - 3189197 3189197
      MOUSE ANTI-INFLUENZA A - 3194596 3194596
      MOUSE ANTI-INFLUENZA A - 3212290 3212290
      MOUSE ANTI-INFLUENZA A - 3221082 3221082
      MOUSE ANTI-INFLUENZA A - 3241214 3241214
      MOUSE ANTI-INFLUENZA A - 3253301 3253301
      MOUSE ANTI-INFLUENZA A - 3254555 3254555

      Referencias bibliográficas

      Visión general referenciasAplicación Pub Med ID
      Discovering neutralizing antibodies targeting the stem epitope of H1N1 influenza hemagglutinin with synthetic phage-displayed antibody libraries.
      Tung, CP; Chen, IC; Yu, CM; Peng, HP; Jian, JW; Ma, SH; Lee, YC; Jan, JT; Yang, AS
      Scientific reports  5  15053  2015

      Mostrar resumen
      26456860 26456860
      Entry properties and entry inhibitors of a human H7N9 influenza virus.
      Si, Y; Li, J; Niu, Y; Liu, X; Ren, L; Guo, L; Cheng, M; Zhou, H; Wang, J; Jin, Q; Yang, W
      PloS one  9  e107235  2014

      Mostrar resumen
      Immunocytochemistry25222852 25222852
      DnaJA1/Hsp40 is co-opted by influenza A virus to enhance its viral RNA polymerase activity.
      Cao, M; Wei, C; Zhao, L; Wang, J; Jia, Q; Wang, X; Jin, Q; Deng, T
      Journal of virology  88  14078-89  2014

      Mostrar resumen
      25253355 25253355
      Single-walled carbon nanotubes increase pandemic influenza A H1N1 virus infectivity of lung epithelial cells.
      Sanpui, P; Zheng, X; Loeb, JC; Bisesi, JH; Khan, IA; Afrooz, AR; Liu, K; Badireddy, AR; Wiesner, MR; Ferguson, PL; Saleh, NB; Lednicky, JA; Sabo-Attwood, T
      Particle and fibre toxicology  11  66  2014

      Mostrar resumen
      25497303 25497303
      Rapidly produced SAM(®) vaccine against H7N9 influenza is immunogenic in mice.
      Hekele, A; Bertholet, S; Archer, J; Gibson, DG; Palladino, G; Brito, LA; Otten, GR; Brazzoli, M; Buccato, S; Bonci, A; Casini, D; Maione, D; Qi, ZQ; Gill, JE; Caiazza, NC; Urano, J; Hubby, B; Gao, GF; Shu, Y; De Gregorio, E; Mandl, CW; Mason, PW; Settembre, EC; Ulmer, JB; Craig Venter, J; Dormitzer, PR; Rappuoli, R; Geall, AJ
      Emerging microbes & infections  2  e52  2013

      Mostrar resumen
      26038486 26038486
      Neurovirulence of H5N1 Infection in Ferrets Is Mediated by Multifocal Replication in Distinct Permissive Neuronal Cell Regions.
      Jennifer R Plourde,John A Pyles,R Colby Layton,Sarah E Vaughan,Jennifer L Tipper,Kevin S Harrod
      PloS one  7  2011

      Mostrar resumen
      23056366 23056366
      Transmission of aerosolized seasonal H1N1 influenza A to ferrets.
      MacInnes, H; Zhou, Y; Gouveia, K; Cromwell, J; Lowery, K; Layton, RC; Zubelewicz, M; Sampath, R; Hofstadler, S; Liu, Y; Cheng, YS; Koster, F
      PloS one  6  e24448  2010

      Mostrar resumen
      21949718 21949718
      Higher level of replication efficiency of 2009 (H1N1) pandemic influenza virus than those of seasonal and avian strains: kinetics from epithelial cell culture and computational modeling.
      Mitchell, H; Levin, D; Forrest, S; Beauchemin, CA; Tipper, J; Knight, J; Donart, N; Layton, RC; Pyles, J; Gao, P; Harrod, KS; Perelson, AS; Koster, F
      Journal of virology  85  1125-35  2010

      Mostrar resumen
      21068247 21068247
      Validation of a method for preparing influenza H5N1 simulated samples.
      John A Lednicky,Julie M Villanueva,Stephen A Burke,Roxanne Shively,Michael W Shaw,Deirdre E Daniels,Sara B Hamilton,Ruben O Donis
      Journal of virological methods  167  2009

      Mostrar resumen
      20362615 20362615
      Recipients of vaccine against the 1976 "swine flu" have enhanced neutralization responses to the 2009 novel H1N1 influenza virus.
      McCullers, JA; Van De Velde, LA; Allison, KJ; Branum, KC; Webby, RJ; Flynn, PM
      Clinical infectious diseases : an official publication of the Infectious Diseases Society of America  50  1487-92  2009

      Mostrar resumen
      20415539 20415539

      Ficha técnica

      Cargo
      MOUSE ANTI-INFLUENZA A